Sat.Aug 24, 2024 - Fri.Aug 30, 2024

article thumbnail

Pharmacogenomics: The Up-and-Coming Field of Pharmacy

Pharmacy Is Right For Me

What is your first thought when you think of a career in pharmacy? You may think of a clinical pharmacist working in a community pharmacy or a hospital pharmacist working in an in-patient unit. But did you think about pharmacogenomics: the field of pharmacy that studies how someone’s genetics affect their response to a certain drug? Not many people are aware of the field of pharmacogenomics, and how it can optimize patient outcomes.

article thumbnail

Free At-Home COVID-19 Test Program Returns as Cases Rise

Drug Topics

The government said the tests will “detect current COVID-19 variants and can be used through the end of the year.

203
203
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tafasitamab, Lenalidomide Combination Modestly Effective in Patients With Large B-Cell Lymphoma

Pharmacy Times

Aligning with previous data, the drug combination was modestly effective in patients with large B-cell lymphoma pre- and post-CAR-T-cell therapy.

154
154
article thumbnail

California, nation’s largest milk producer, discloses possible bird flu outbreaks in three dairy cow herds

STAT

On Thursday, the California Department of Food and Agriculture announced it is investigating the possible introduction of H5N1 bird flu in cattle at three dairy farms in the Central Valley. If confirmed, they would be the first known cases in that state. In a statement, officials said testing of samples from the three farms is currently underway in the state’s veterinary diagnostic lab.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The Importance of Reaching Out: Why Talking to Someone Matters

Pharmacy Is Right For Me

As the school year begins, students often find themselves juggling a variety of responsibilities—homework, extracurricular activities, social commitments, and more. For those with aspirations in the demanding field of pharmacy, the pressure to excel can sometimes feel overwhelming. During these moments, it’s essential to remember that you don’t have to navigate challenges alone.

article thumbnail

Psilocybin Mushrooms: A Journey from Ancient Traditions to Modern Clinical Use

Drug Topics

As research continues to uncover the potential benefits of psilocybin, pharmacists and other clinicians have an essential role in bridging ancient wisdom with contemporary science.

179
179

More Trending

article thumbnail

STAT+: UnitedHealth pledged a hands-off approach after buying a Connecticut medical group. Then it upended how doctors practice

STAT

MIDDLETOWN, Conn. — UnitedHealth Group told the Connecticut primary care doctors everything they wanted to hear. Take our money, the company said, and together we can bring about a future where primary care leads. A future where doctors can take better care of their patients, and reap the financial rewards of improved health. We’ll handle the business side while you look after your patients.

145
145
article thumbnail

Eli Lilly rolls out direct patient access to weight loss star Zepbound—at a deep discount

Fierce Pharma

Eli Lilly has come up with a new way of supplying its popular weight-loss drug Zepbound that the company hopes could expand access while addressing other issues such as high prices and off-label co | Eli Lilly is offering its popular weight-loss drug Zepbound directly to consumers at a discount through its own online pharmacy. The company hopes the move could expand access while addressing other issues such as high prices and off-label cosmetic usage.

Labelling 137
article thumbnail

High-Dose, Adjuvanted Flu Vaccines Prove More Effective for Older Adults

Drug Topics

“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.

Vaccines 168
article thumbnail

Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report

Pharmacy Times

The request comes as increased scrutiny is levied toward pharmacy benefit managers for alleged unfair business practices.

147
147
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

21 cases of little-known Oropouche virus detected in U.S.

STAT

Nearly two dozen people in the United States have been confirmed to have contracted the Oropouche virus during travels outside the country this summer, the Centers for Disease Control and Prevention reported Tuesday. A previously little-known virus, Oropouche has garnered headlines in recent weeks with reports of a small number of deaths and a possible link to congenital malformations in babies infected in the womb.

145
145
article thumbnail

After an FDA rejection, here’s what’s next in the psychedelics pipeline

PharmaVoice

By rejecting the first MDMA therapy earlier this month, the FDA signaled to the psychedelic drug sector that the road to approval isn’t clear cut.

FDA 134
article thumbnail

Dexcom’s OTC Continuous Glucose Monitor Now Available in US

Drug Topics

The Stelo glucose biosensor system is intended for use in adults who do not use insulin or in those without diabetes who wish to better understand how diet and exercise affect blood glucose levels.

154
154
article thumbnail

Fish Oil Supplementation May Reduce Genetic Risk of High Cholesterol

Pharmacy Times

Pharmacists can be essential sources of education for patients, offering them guidance on safe use and proper dosage.

Dosage 144
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Opinion: Why Harvard, Penn, and Columbia have turned to M.D.s for leadership in troubled times

STAT

Recently, Columbia University’s president resigned after months of chaos, following in the footsteps of Harvard and my own institution, Penn. Besides struggling with encampments, building takeovers, and commencement challenges, the three universities have something else in common: They have all chosen M.D.s as president or interim president.

145
145
article thumbnail

Recent moves by Epic, Carequality mark a major shift in interoperability, health IT experts say

Fierce Healthcare

Electronic health records giant Epic recently announced plans to transition its customers to a new government-backed data exchange by the end of next year. | Carequality and Epic both revealed plans to align with TEFCA, signaling potentially a "tectonic shift" in the interoperability landscape and the rising influence of the federal government's nascent network, health IT experts say.

134
134
article thumbnail

Merck’s Keytruda flunks pivotal studies in early-stage lung and skin cancers

Fierce Pharma

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer. | A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.

128
128
article thumbnail

PQA Issues Call to Action to Improve Medication Therapy Management

Pharmacy Times

Eight areas of improvement were developed as part of national initiative with stakeholder involvement.

142
142
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Fauci recovering at home following hospitalization for West Nile virus infection

STAT

Anthony Fauci, former head of the National Institute of Allergy and Infectious Diseases, is recovering at home after being hospitalized for nearly a week for West Nile virus infection. Fauci, a leader of the U.S. Covid-19 response, spent six days in hospital as doctors tried to figure out what was responsible for his illness. It was thought he had a bacterial infection, or had been infected with a tick-borne disease, until a blood test showed he was “strongly positive” for West Nil

Hospitals 145
article thumbnail

Feds killed plan to curb Medicare Advantage overbilling after industry opposition

Fierce Healthcare

A decade ago, federal officials drafted a plan to discourage Medicare Advantage health insurers from overcharging the government by billions of dollars—only to abruptly back off amid an “uproar” fr | Filings and testimonies in a multibillion-dollar Justice Department civil fraud case against UnitedHealth Group outline industry pressure that led the government to bury a proposed rule on Medicare Advantage chart reviews.

Insurance 132
article thumbnail

BioMarin cuts deeper with 225 layoffs under CEO's new corporate strategy

Fierce Pharma

The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech. | The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech.

128
128
article thumbnail

Patients With Asthma Experience Changes in Airway Inflammation Following Electronic Cigarette Use

Pharmacy Times

Using 1 nicotine-containing electronic cigarette was significantly correlated with an increase in residual volume and total lung capacity in patients with asthma.

139
139
article thumbnail

What you need to know about West Nile virus

STAT

News that Anthony Fauci, long-time former head of the National Institute of Allergy and Infectious Diseases, is recovering from a bad bout of West Nile virus fever throws a spotlight on a disease that sickens plenty of Americans every summer, but which gets little attention. Transmitted by mosquitoes, the virus causes symptom-free infections in most people who contract it.

Hospitals 145
article thumbnail

Rep. Comer threatens PBM execs with fines, jail time over 'fraudulent' hearing testimony

Fierce Healthcare

A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry. | A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry.

124
124
article thumbnail

SCOTUS overturn of Chevron doctrine opens a Pandora's box for biopharma industry, expert says

Fierce Pharma

For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of federal agencies. | In June, when the Supreme Court voted 6-3 to overturn the Chevron doctrine, it brought significant impact for the healthcare industry and federal regulators like the FDA and the Centers for Medicare & Medicaid Services.

FDA 124
article thumbnail

The Perfect Ingredient: Vaccine Education With Pharmacy Community Health Workers

Pharmacy Times

In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.

Vaccines 139
article thumbnail

Opinion: To stop mpox from becoming the next pandemic, we must address global vaccine inequities

STAT

In early 2022, I cared for one of the first patients with mpox in Massachusetts. As an infectious diseases physician, I remember the deep uncertainty I felt, and the fear in my patient’s eyes as a painful rash spread over their body. We were in uncharted territory — there were no proven treatments, and the number of cases was rapidly increasing.

Vaccines 144
article thumbnail

TennCare violated healthcare rights of Tennessee Medicaid beneficiaries, judge rules

Fierce Healthcare

TennCare, the state of Tennessee’s Medicaid program, intentionally prevented families from receiving healthcare coverage and benefits, a federal district judge determined Aug. 26. | TennCare, the Tennessee state Medicaid program, was found to have intentionally prevented families from receiving healthcare coverage and benefits, a federal court found.

124
124
article thumbnail

FDA Roundup: Agency Highlights from August 2024

Drug Topics

Checkout these important FDA updates from the month of August 2024.

FDA 123
article thumbnail

FDA Clears Omnipod 5 Automated Insulin Delivery System for Use in Adults With Type 2 Diabetes

Pharmacy Times

Previously, the device was indicated for the management of type 1 diabetes in patients aged 2 years and older.

FDA 134
article thumbnail

STAT+: The weight loss drug shortage is driving patients to Hims. What happens when the shortage ends?

STAT

Hims & Hers, one of the largest publicly traded telehealth companies in the country, has supercharged its business in the last several months by offering compounded versions of the patented weight loss drugs known as GLP-1s. It’s staking its future on the drugs, with plans to continue selling compounded GLP-1s even when shortages of the versions approved by regulators come to an end — a strategy that policy experts say could land the company in court.

article thumbnail

Waltz Health debuts specialty pharmacy platform, partners with Reliance Rx to slash drug costs

Fierce Healthcare

A new specialty pharmacy program by digital health company Waltz Health has been created to lower costs for payers and provide better experiences for patients and pharmacies. | Waltz Connect will use its AI engine to route specialty drug prescriptions to the most ideal location for payers and patients based on weighted attributes. The company is also partnering with Reliance Rx.

article thumbnail

Novartis taps Lindy to turn biologic drugs into at-home injectables, puts nearly $1B on the line

Fierce Pharma

Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs. | Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs.

123
123